ConductScience.org, home

Trial · NCT06997952

Febuxostat Effect on Chronic Kidney Disease Progression And Carotid Intima-Media Thickness

NCT06997952, Phase 1, Completed, Ain Shams University

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Febuxostat Effect on Chronic Kidney Disease Progression And Carotid Intima-Media Thickness. Trials, record NCT06997952. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06997952

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Febuxostat Effect on Chronic Kidney Disease Progression And Carotid Intima-Media Thickness
NCT number
NCT06997952
Status
Completed
Phases
Phase 1
Enrollment
50 participants, actual
Lead sponsor
Ain Shams University
Conditions
Carotid Intima- Media Thickness
Interventions
Febuxostat 40 mg
First posted
2025-05-31
Last updated
2026-07-29

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in estimated glomerular filtration rate (eGFR) from baseline to 12 weeks3 months
Change in estimated glomerular filtration rate (eGFR), calculated using the CKD-EPI equation and expressed as mL/min/1.73 m², from baseline to 12 weeks following administration of febuxostat compared with the control group.
PrimaryChange in proteinuria from baseline to 12 weeks3 monthsChange in proteinuria, assessed by the urine protein-to-creatinine ratio (Pr/Cr ratio, mg/g), from baseline to 12 weeks following administration of febuxostat compared with the control group.
SecondaryChange in carotid intima-media thickness (CIMT) measured by carotid duplex from baseline to 12 weeks3 months
Change in carotid intima-media thickness (CIMT), assessed by carotid duplex imaging, from baseline to 12 weeks following administration of febuxostat compared with the control group. CIMT will be measured in millimetres (mm) using a standardized carotid duplex protocol.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06997952

GET https://conductscience.org/api/trials/v1/NCT06997952/registered